Swiss pharmaceutical giant Roche is buying up the rest of the shares in California-based Genentech. The combined group will be the seventh-largest drugs company in the U.S. Stephen Beard reports what new powers this will give Roche.
A recent open house at a popular LA hair transplant clinic was packed with men. But LA Times business columnist David Lazarus told Bill Radke the rise in demand is less for vanity and more to maintain a competitive edge in the job market.
New technology and increased funding is allowing doctors to monitor their patients' health virtually through computer chips. But as technology revolutionizes the health care field, there are some kinks to be worked out. Caitlan Carroll reports.
Drug makers Merck and Schering-Plough will join forces under Merck's name in a deal worth $41 billion in cash and stock. Steve Chiotakis talks to Ashley Milne-Tyte about how both companies stand to benefit from the deal.
At a forum, President Obama discussed reforming the health care system with leaders in the field. Aetna CEO Ronald Williams speaks with Kai Ryssdal about some of the things Obama will have to consider to fix the system.
A big portion of President Obama's stimulus package is directed at increasing health coverage for more Americans. But commentator Edward Miguel says the new focus on fixing health care will put stress on Obama's bipartisan pledge.